FHIR R6 Patient Care Incubator, published by HL7 International / Patient Care. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/pc-incubator/ and changes regularly. See the Directory of published versions
<ConditionDefinition xmlns="http://hl7.org/fhir">
<id value="example"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ConditionDefinition example</b></p><a name="example"> </a><a name="hcexample"> </a><p><b>url</b>: <a href="http://hl7.org/fhir/ConditionDefinition/example">http://hl7.org/fhir/ConditionDefinition/example</a></p><p><b>identifier</b>: <a href="http://terminology.hl7.org/7.1.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt
This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid:
Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.
This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: Active</p><p><b>date</b>: 2019-05-26 10:44:00+1000</p><p><b>description</b>: </p><div><p>Hyperlipidemia Status</p>
</div><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 55822004}">Hyperlipidemia (disorder)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><p><b>observation</b>: <code>http://example.org/fhir/ObservationDefinition/lipid-panel</code>, <code>http://example.org/fhir/ObservationDefinition/cholesterol</code>, <code>http://example.org/fhir/ObservationDefinition/triglyceride</code>, <code>http://example.org/fhir/ObservationDefinition/cholesterol-hdl</code>, <code>http://example.org/fhir/ObservationDefinition/cholesterol-ldl</code></p><h3>Medications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 203151}">Gemfibrozil</span></td></tr></table><h3>Plans</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td><a href="http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div>
</text>
<url value="http://hl7.org/fhir/ConditionDefinition/example"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.25.1"/>
</identifier>
<name value="Hyperlipidemia"/>
<title value="Hyperlipidemia Status"/>
<status value="active"/>
<date value="2019-05-26T10:44:00+10:00"/>
<description value="Hyperlipidemia Status"/>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="55822004"/>
<display value="Hyperlipidemia (disorder)"/>
</coding>
</code>
<hasSeverity value="false"/>
<hasBodySite value="false"/>
<hasStage value="false"/>
<definition
value="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"/>
<observation
value="http://example.org/fhir/ObservationDefinition/lipid-panel"/>
<observation
value="http://example.org/fhir/ObservationDefinition/cholesterol"/>
<observation
value="http://example.org/fhir/ObservationDefinition/triglyceride"/>
<observation
value="http://example.org/fhir/ObservationDefinition/cholesterol-hdl"/>
<observation
value="http://example.org/fhir/ObservationDefinition/cholesterol-ldl"/>
<!--
<observation>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="24331-1"/>
<display value="Lipid 1996 panel - Serum or Plasma"/>
</coding>
<text value="Lipid Panel"/>
</code>
</observation>
<observation>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="35200-5"/>
<display value="Cholesterol [Mass or Moles/volume] in Serum or Plasma"/>
</coding>
<text value="Cholesterol"/>
</code>
</observation>
<observation>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="35217-9"/>
<display value="Triglyceride [Mass or Moles/volume] in Serum or Plasma"/>
</coding>
<text value="Triglyceride"/>
</code>
</observation>
<observation>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="2085-9"/>
<display value="Cholesterol in HDL [Mass/volume] in Serum or Plasma"/>
</coding>
<text value="Cholesterol in HDL"/>
</code>
</observation>
<observation>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="13457-7"/>
<display value="Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"/>
</coding>
<text value="LDL Chol. (Calc)"/>
</code>
</observation>
-->
<medication>
<code>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="203151"/>
<display value="fenoldopam mesylate"/>
</coding>
<text value="Gemfibrozil"/>
</code>
</medication>
<plan>
<reference>
<reference
value="http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"/>
</reference>
</plan>
</ConditionDefinition>